A platform for sharing breast cancer imaging data and improving patient outcomes
Elucidating the Impact of Social Wellness and Artificial Intelligence on the Psychological Consequences of Breast Cancer Imaging
University of Central Florida · NCT06604078
This study is testing a new online platform where breast cancer patients can share their imaging experiences to see if it helps reduce anxiety and improve outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Central Florida (other) |
| Locations | 1 site (Orlando, Florida) |
| Trial ID | NCT06604078 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on developing MammoChat, a social health platform that enables patients to anonymously share their breast imaging experiences and data. By utilizing standardized questionnaires, the study aims to assess the impact of this social network on psychological outcomes related to breast cancer screening, such as anxiety. Additionally, the study will create a crowdsourced repository of de-identified radiographic data to train and validate AI models for earlier and more accurate breast cancer detection. The initiative is supported by the University of Central Florida College of Medicine.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have undergone breast cancer imaging tests in the US.
Not a fit: Patients who are minors, prisoners, or unable to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this platform could significantly reduce anxiety and improve the overall experience of patients undergoing breast cancer screening.
How similar studies have performed: While the use of social networks and AI in healthcare is emerging, this specific approach to breast cancer imaging is novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults, ages 18 and older * Had a radiographic breast cancer imaging test, either for screening or diagnosis of breast cancer, with either positive or negative results performed in a US institution. * Have an email account with access to a reliable internet connection or smartphone Exclusion Criteria: * Minors , ages under 18 * Prisoners. Given the repository design, prisoners are unlikely to participate and provide a consent * Adults who are unable to provide consent.
Where this trial is running
Orlando, Florida
- University of Central Florida — Orlando, Florida, United States (RECRUITING)
Study contacts
- Principal investigator: Dexter Hadley, M.D., PhD, M.S.E — University of Central Florida
- Study coordinator: Amoy Fraser, PhD, CCRP, PMP
- Email: amoy.fraser@ucf.edu
- Phone: 4072668742
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer, Breast Cancer Screening, Artifical Inteligence, AI